An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease

ClinicalTrials.gov ID: NCT00790933

Public ClinicalTrials.gov record NCT00790933. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:53 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab (MLN0002) in Subjects With Ulcerative Colitis and Crohn's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this multicenter, open-label study is to collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (MLN0002) administration.

Study identification

NCT ID: NCT00790933
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Takeda; Industry
Enrollment: 2,243 participants

Conditions and interventions

Conditions

Interventions

Vedolizumab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 22, 2009 (Actual)
Primary completion: Oct 31, 2017 (Actual)
Completion: Oct 31, 2017 (Actual)
Last update posted: May 24, 2022

2009 – 2017

United States locations

U.S. sites: 31
U.S. states: 19
U.S. cities: 31

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	35233	—
Not listed	San Diego	California	92114	—
Not listed	San Francisco	California	94115	—
Not listed	Lafayette	Colorado	80026	—
Not listed	Littleton	Colorado	80120	—
Not listed	Thornton	Colorado	80229	—
Not listed	Hamden	Connecticut	06518	—
Not listed	Jacksonville	Florida	32256	—
Not listed	Miami	Florida	33172	—
Not listed	Winter Park	Florida	32789	—
Not listed	Atlanta	Georgia	30024	—
Not listed	Decatur	Georgia	30033	—
Not listed	Macon	Georgia	31201	—
Not listed	Topeka	Kansas	66606	—
Not listed	Louisville	Kentucky	40202	—
Not listed	Baton Rouge	Louisiana	70809	—
Not listed	Chevy Chase	Maryland	20815	—
Not listed	Ann Arbor	Michigan	48109	—
Not listed	Troy	Michigan	48098	—
Not listed	Rochester	Minnesota	55904	—
Not listed	Cheektowaga	New York	10029	—
Not listed	New York	New York	10029	—
Not listed	Charlotte	North Carolina	28207	—
Not listed	Elkin	North Carolina	28621	—
Not listed	Portland	Oregon	97225	—
Not listed	Germantown	Tennessee	38138	—
Not listed	San Antonio	Texas	78229	—
Not listed	Tyler	Texas	75701	—
Not listed	Charlottesville	Virginia	22908	—
Not listed	Richmond	Virginia	23249	—
Not listed	Milwaukee	Wisconsin	53226	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00790933, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 24, 2022 · Synced Nov 7, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00790933 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →